科研製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2017/05/10 | 6,940 | 6,970 | 6,650 | 6,890 | -60 | -0.9% | 494,000 |
2017/05/09 | 6,810 | 6,950 | 6,800 | 6,950 | +80 | +1.2% | 151,000 |
2017/05/08 | 6,810 | 6,900 | 6,810 | 6,870 | +160 | +2.4% | 272,900 |
2017/05/02 | 6,690 | 6,740 | 6,680 | 6,710 | +40 | +0.6% | 119,600 |
2017/05/01 | 6,610 | 6,670 | 6,580 | 6,670 | +60 | +0.9% | 157,100 |
2017/04/28 | 6,550 | 6,610 | 6,540 | 6,610 | +100 | +1.5% | 144,100 |
2017/04/27 | 6,550 | 6,590 | 6,480 | 6,510 | -120 | -1.8% | 190,200 |
2017/04/26 | 6,600 | 6,640 | 6,550 | 6,630 | +80 | +1.2% | 164,100 |
2017/04/25 | 6,570 | 6,590 | 6,510 | 6,550 | -20 | -0.3% | 115,800 |
2017/04/24 | 6,500 | 6,570 | 6,490 | 6,570 | +110 | +1.7% | 138,900 |
2017/04/21 | 6,400 | 6,460 | 6,360 | 6,460 | +90 | +1.4% | 133,100 |
2017/04/20 | 6,380 | 6,420 | 6,310 | 6,370 | -10 | -0.2% | 166,200 |
2017/04/19 | 6,320 | 6,410 | 6,320 | 6,380 | +10 | +0.2% | 168,800 |
2017/04/18 | 6,300 | 6,380 | 6,260 | 6,370 | +40 | +0.6% | 141,600 |
2017/04/17 | 6,080 | 6,340 | 6,080 | 6,330 | +180 | +2.9% | 163,900 |
2017/04/14 | 6,280 | 6,280 | 6,130 | 6,150 | -110 | -1.8% | 142,200 |
2017/04/13 | 6,260 | 6,280 | 6,220 | 6,260 | ±0 | ±0% | 149,800 |
2017/04/12 | 6,230 | 6,260 | 6,180 | 6,260 | -70 | -1.1% | 200,400 |
2017/04/11 | 6,310 | 6,340 | 6,270 | 6,330 | ±0 | ±0% | 183,500 |
2017/04/10 | 6,460 | 6,480 | 6,300 | 6,330 | -150 | -2.3% | 231,900 |
2017/04/07 | 6,450 | 6,490 | 6,360 | 6,480 | +130 | +2% | 208,100 |
2017/04/06 | 6,430 | 6,450 | 6,310 | 6,350 | -110 | -1.7% | 218,400 |
2017/04/05 | 6,400 | 6,460 | 6,380 | 6,460 | +80 | +1.3% | 143,500 |
2017/04/04 | 6,380 | 6,460 | 6,350 | 6,380 | -20 | -0.3% | 258,100 |
2017/04/03 | 6,300 | 6,430 | 6,290 | 6,400 | +110 | +1.7% | 182,700 |
2017/03/31 | 6,400 | 6,460 | 6,290 | 6,290 | -100 | -1.6% | 208,500 |
2017/03/30 | 6,540 | 6,540 | 6,390 | 6,390 | -140 | -2.1% | 171,400 |
2017/03/29 | 6,610 | 6,640 | 6,500 | 6,530 | -110 | -1.7% | 191,200 |
2017/03/28 | 6,550 | 6,660 | 6,540 | 6,640 | +130 | +2% | 185,900 |
2017/03/27 | 6,530 | 6,560 | 6,470 | 6,510 | -40 | -0.6% | 107,500 |
2017/03/24 | 6,460 | 6,570 | 6,430 | 6,550 | +100 | +1.6% | 141,700 |
2017/03/23 | 6,380 | 6,450 | 6,320 | 6,450 | +80 | +1.3% | 157,700 |
2017/03/22 | 6,380 | 6,420 | 6,350 | 6,370 | -60 | -0.9% | 157,900 |
2017/03/21 | 6,410 | 6,450 | 6,400 | 6,430 | +20 | +0.3% | 120,900 |
2017/03/17 | 6,350 | 6,420 | 6,330 | 6,410 | ±0 | ±0% | 169,100 |
2017/03/16 | 6,330 | 6,420 | 6,320 | 6,410 | +60 | +0.9% | 165,000 |
2017/03/15 | 6,310 | 6,370 | 6,280 | 6,350 | +20 | +0.3% | 117,500 |
2017/03/14 | 6,300 | 6,340 | 6,250 | 6,330 | +30 | +0.5% | 125,700 |
2017/03/13 | 6,290 | 6,310 | 6,260 | 6,300 | +70 | +1.1% | 126,200 |
2017/03/10 | 6,190 | 6,250 | 6,180 | 6,230 | +80 | +1.3% | 207,300 |
2017/03/09 | 6,140 | 6,170 | 6,090 | 6,150 | +60 | +1% | 154,400 |
2017/03/08 | 6,150 | 6,170 | 6,090 | 6,090 | -70 | -1.1% | 183,200 |
2017/03/07 | 6,130 | 6,170 | 6,100 | 6,160 | +30 | +0.5% | 127,800 |
2017/03/06 | 6,100 | 6,160 | 6,090 | 6,130 | ±0 | ±0% | 181,600 |
2017/03/03 | 6,130 | 6,160 | 6,100 | 6,130 | -10 | -0.2% | 166,200 |
2017/03/02 | 6,150 | 6,160 | 6,120 | 6,140 | +50 | +0.8% | 160,400 |
2017/03/01 | 6,020 | 6,120 | 6,020 | 6,090 | +50 | +0.8% | 165,700 |
2017/02/28 | 6,080 | 6,130 | 6,040 | 6,040 | +20 | +0.3% | 235,000 |
2017/02/27 | 5,970 | 6,050 | 5,960 | 6,020 | +10 | +0.2% | 191,200 |
2017/02/24 | 5,940 | 6,040 | 5,930 | 6,010 | +50 | +0.8% | 166,900 |
1951~
2000
件表示中 / 3692件
類似銘柄と比較する
現在ご覧いただいている「科研薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
科研薬 | 407,200円 | +30.5% | +111.0% | 4.67% | 11.48倍 | 1.00倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
日本新薬 | 373,500円 | +7.9% | +8.9% | 3.32% | 7.99倍 | 1.07倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
サワイGHD | 203,300円 | +4.0% | +25.4% | 2.61% | 8.89倍 | 1.17倍 |
|
ジェネリック(後発)薬大手メーカー。21年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
キッセイ薬 | 379,500円 | +14.5% | -2.3% | 2.37% | 13.88倍 | 0.74倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
サンバイオ | 229,900円 | - | - | 0.00% | - | 106.48倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム